All posts by medical

Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now – Yahoo Finance

November 20, 2024 medical

Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now Yahoo Finance

See the original post:
Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance

Precision mutational scanning: your multipass to the future of genetics – Nature.com

November 20, 2024 medical

Precision mutational scanning: your multipass to the future of genetics Nature.com

Read this article:
Precision mutational scanning: your multipass to the future of genetics - Nature.com

Advancements of Haploid Technology in Crops: New Horizons in Breeding and Genetics – Frontiers

November 20, 2024 medical

Advancements of Haploid Technology in Crops: New Horizons in Breeding and Genetics Frontiers

See more here:
Advancements of Haploid Technology in Crops: New Horizons in Breeding and Genetics - Frontiers

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET – Business Wire

November 20, 2024 medical

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET Business Wire

Read the original post:
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET - Business Wire

Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough – Infection Control Today

November 20, 2024 medical

Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough Infection Control Today

View original post here:
Discovering Solutions for Long COVID: A T-Cell Immunology Breakthrough - Infection Control Today

TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development – Business Wire

November 20, 2024 medical

TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development Business Wire

Continued here:
TRexBio Announces $84 Million Series B Financing to Advance Pipeline of First-in-Class Immunology Programs into Clinical Development - Business Wire

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 – The Bakersfield Californian

November 20, 2024 medical

Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 The Bakersfield Californian

Read more:
Innate Pharma Announces Publication in Science Immunology Highlighting Innovative Next-generation ANKET IPH6501 - The Bakersfield Californian

Immunology Data Shows INOVIO’s INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of…

November 20, 2024 medical

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial Yahoo Finance

Continued here:
Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of...

Biology

Biology Beyond the Classroom: Belize Study Abroad Course Offers Hands-On Experience College of Arts & Sciences – UofL Today

November 20, 2024 medical

Biology Beyond the Classroom: Belize Study Abroad Course Offers Hands-On Experience College of Arts & Sciences UofL Today

View original post here:

Biology Beyond the Classroom: Belize Study Abroad Course Offers Hands-On Experience College of Arts & Sciences - UofL Today

Biology

A climate fund is way too generic, says Nucleus Capital – as it launches 40m fund focused on synthetic biology – Sifted

November 20, 2024 medical

A climate fund is way too generic, says Nucleus Capital - as it launches 40m fund focused on synthetic biology Sifted

Excerpt from:

A climate fund is way too generic, says Nucleus Capital - as it launches 40m fund focused on synthetic biology - Sifted